Aspira women's health announces closing of $1.37 million private placement of convertible notes

Austin, tx / access newswire / march 11, 2025 / aspira women's health inc. ("aspira" or the "company") (nasdaq:awh), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools, today announced that it has entered into a securities purchase agreement dated march 6, 2025, pursuant to which the company has sold and issued an aggregate principal amount of $1.37 million in the form of senior secured convertible promissory notes due march 6, 2030 (the "convertible notes") in a private placement (the "private placement") with existing and new accredited investors. the convertible notes will be a senior, secured obligation of the company and interest will accrue and be payable quarterly in kind at the applicable federal rate (currently 3.34%).
AWH Ratings Summary
AWH Quant Ranking